Warning: Declaration of YOOtheme\Theme\Wordpress\MenuWalker::walk($elements, $max_depth) should be compatible with Walker::walk($elements, $max_depth, ...$args) in /home/hithotto/public_html/naloxone.org.uk/wp-content/themes/yootheme/vendor/yootheme/theme-wordpress/src/MenuWalker.php on line 8

Research shows nasal spray antidote is easiest to give for opioid overdose

Of three possible ways for people to deliver the life-saving antidote naloxone to a person experiencing an opioid overdose, the use of a nasal spray was the quickest and easiest according to research conducted by William Eggleston, clinical assistant professor at Binghamton University, State University of New York, and colleagues at SUNY Upstate Medical University.

Continue reading

Harm Reduction programs distribute one million doses of naloxone in 2019

2019 marks the close of a decade of unimaginable loss to our communities. Likely an underestimate, we lost half a million of our friends in these last ten years to the War on Drugs-fueled overdose crisis. With deep reverence for this painful truth, we want to take a moment to uplift and reflect upon the power of one small group of Harm Reduction programs who were responsible for distributing an enormous portion of the nation’s naloxone directly to people who use drugs and those who love them this past year.

Continue reading

Implant developed to release overdose-reversing naloxone

An opioid overdose can be a lonely death. People who use drugs often do so in private, and should they get a dose stronger than they can tolerate, no one will be there to save them with the overdose-reversing medication naloxone. But now, a researcher at Northwestern University is developing a technological fix to that lethal conundrum.

Continue reading

Saving Lives: Best practice guidance on the provision of naloxone

Release have developed best practice guidance for the provision of naloxone. Building on the findings from Release’s research on naloxone in England, Release hosted the Naloxone Steering Group 2019 in April 2019, in partnership with the National Addiction Centre at King’s College London. The objective of the steering group was to get key stakeholders together for a day to discuss some of the main aspects of naloxone provision in the UK and to produce guidelines on the provision of naloxone for people who might experience or witness an opioid overdose.

Continue reading

This website has been made possible through the provision of an arm length/unrestricted educational grant from Ethypharm. Ethypharm do not control and are not liable for any of the content placed, or any of the claims that may be made, on this site.

HIT